In silico Identification of potential 5α‒reductase inhibitors for prostatic diseases: QSAR modelling, molecular docking, and pre ADME predictions

@article{Dhingra2018InSI,
  title={In silico Identification of potential 5$\alpha$‒reductase inhibitors for prostatic diseases: QSAR modelling, molecular docking, and pre ADME predictions},
  author={Neelima Dhingra},
  journal={MOJ Drug Design Development \& Therapy},
  year={2018}
}
  • N. Dhingra
  • Published 12 June 2018
  • Biology, Medicine
  • MOJ Drug Design Development & Therapy
Steroids assume an essential part in a several processes, ranging from the differentiation, growth, development, physiological and regenerative functions in the human body,1 because of their ability to cross membrane easily.2 Steroids as well as their derivatives have the potential to be developed as drugs for the treatment of a large number of diseases including cardiovascular, autoimmune diseases, brain tumours, breast cancer, osteoarthritis, prostate cancer etc.3‒6 The promise of using… 

References

SHOWING 1-10 OF 33 REFERENCES

Androgen Regulation of 5α-Reductase Isoenzymes in Prostate Cancer: Implications for Prostate Cancer Prevention

It is found that androgen regulates the mRNA level of 5α-reductase isoenzymes in a cell type–specific manner, that regulation occurs at the transcriptional level, and that AR is necessary for this regulation.

Novel 5α‐steroid reductase (SRD5A3, type‐3) is overexpressed in hormone‐refractory prostate cancer

Findings indicate that a novel type 3 5α‐steroid reductase, SRD5A3, is associated with DHT production and maintenance of androgen–androgen receptor‐pathway activation in HRPC cells, and that this enzymatic activity should be a promising molecular target for prostate cancer therapy.

Benign prostatic hyperplasia: an insight into current investigational medical therapies

With the initial success of upcoming targets, the unmet need to develop an efficacious and relatively safe therapeutic modality is discussed and their long-term safety and efficacy needs to be evaluated in large-scale clinical trials.

Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones.

This review presents a detailed description of the enzymes involved in the biosynthesis of active steroid hormones, with emphasis on the human and mouse enzymes and their expression in gonads, adrenal glands, and placenta.

Species Differences in Prostatic Steroid 5α-Reductases of Rat, Dog, and Human

The conversion of testosterone to 5a-dihydrotestosterone by prostate particulates from rats, dogs, and humans was investigated, and significant species differences were found with their pH profiles,

Computational Analysis of Physicochemical, Pharmacokinetic and Toxicological Properties of Deoxyhypusine Synthase Inhibitors with Antimalarial Activity

15 most active inhibitors of deoxyhypusine synthase target are investigated in order to trace a pattern of physicochemical, pharmacokinetic and toxicological properties of the inhibitors for this enzyme and three new inhibitors are proposed, being able to reach less adverse effects related to the central nervous system depending of administered dose.